Serum Markers of Bone Turnover Are Increased at Six and 18 Months After Roux-en-Y Bariatric Surgery: Correlation with the Reduction in Leptin

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2009 Oct 28

PMID 19858320

Citations 56

Authors

Carolina Bruno

Angie D Fulford

Jenna R Potts

Ronald McClintock

Rosemarie Jones

Brenda M Cacucci

Christine E Gupta

Munro Peacock

Robert V Considine

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of the study was to examine serum markers of bone turnover at 6 and 18 months after Roux-en-Y gastric bypass surgery.

Participants: Ten women and 10 men [body mass index (BMI), 50.2 +/- 8.4 kg/m(2)] were studied at 6 months; 10 women and nine men (BMI, 47.2 +/- 6.6 kg/m(2)) were studied at 18 months after surgery.

Main Outcome Measures: Serum osteocalcin, bone specific alkaline phosphatase (BAP), N-telopeptide of type 1 collagen (NTX), PTH, 25-hydroxy vitamin D, and leptin were measured.

Results: BMI was reduced 32.7 +/- 6.2% at 6 months after surgery. Serum osteocalcin (6.9 +/- 2.4 to 10.9 +/- 2.6 ng/ml; P < 0.0001), BAP (14.2 +/- 3.7 to 16.4 +/- 4.5 ng/ml; P = 0.04), and NTX (10.9 +/- 1.7 to 19.6 +/- 5.3 nm bone collagen equivalents; P < 0.0001) were increased. Calcium, phosphate, and PTH were unchanged, but 25-hydroxy vitamin D increased (16.0 +/- 8.9 vs. 26.9 +/- 10.6 ng/ml; P <0.0001). The increase in NTX correlated with reduction in serum leptin (r = 0.58; P = 0.007). BMI was reduced 40.9 +/- 7.5% at 18 months after surgery. Serum BAP (17.6 +/- 5.3 to 22.2 +/- 7.8 ng/ml; P = 0.0017) and NTX (10.8 +/- 2.7 to 16.9 +/- 5.5 nm bone collagen equivalents; P < 0.0001) were increased. Calcium, phosphate, and PTH were unchanged, but 25-hydroxy vitamin D increased (17.7 +/- 7.6 to 25.6 +/- 6.8 ng/ml; P < 0.0001). The increase in NTX correlated with reduction in BMI (r = 0.58; P = 0.009) and leptin (r = 0.45; P = 0.04) and the increase in serum 25-hydroxy vitamin D (r = 0.43; P = 0.05). In multiple regression (adjusted model R(2) 0.263; P = 0.013), reduction in leptin was a significant predictor of increase in NTX (P = 0.016), but changes in BMI and 25-hydroxy vitamin D were not.

Conclusions: Weight loss after bariatric surgery is associated with long-term increase in serum markers of bone turnover. The increase in NTX is related to the decrease in leptin, which may signal caloric restriction to the skeleton.

Citing Articles

Changes in Nutritional Outcomes After Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis.

Duan L, Wang Y, Cheng L, Wang J Obes Surg. 2024; 34(6):2116-2129.

PMID: 38662252 DOI: 10.1007/s11695-024-07232-2.

[Impact of surgical treatment of morbid obesity on joint diseases].

Panevin T, Zotkin E, Lila A Probl Endokrinol (Mosk). 2023; 69(4):70-76.

PMID: 37694869 PMC: 10520909. DOI: 10.14341/probl13258.

Bone Health after Bariatric Surgery: Consequences, Prevention, and Treatment.

Sayadi Shahraki M, Mahmoudieh M, Kalidari B, Melali H, Mousavi M, Ghourban Abadi M Adv Biomed Res. 2022; 11:92.

PMID: 36518856 PMC: 9744087. DOI: 10.4103/abr.abr_182_21.

Vitamin D and Visceral Obesity in Humans: What Should Clinicians Know?.

Shantavasinkul P, Nimitphong H Nutrients. 2022; 14(15).

PMID: 35893929 PMC: 9332747. DOI: 10.3390/nu14153075.

Bone metabolism in Chinese patients after laparoscopic Roux-en-Y gastric bypass.

Wang C, Zhang H, Xu T, Zou J, Chen J, Zhang P Transl Cancer Res. 2022; 9(4):2534-2541.

PMID: 35117613 PMC: 8799154. DOI: 10.21037/tcr.2020.03.01.

References

DeMaria E . Bariatric surgery for morbid obesity. N Engl J Med. 2007; 356(21):2176-83. DOI: 10.1056/NEJMct067019. View

Hamoui N, Anthone G, Crookes P . Calcium metabolism in the morbidly obese. Obes Surg. 2004; 14(1):9-12. DOI: 10.1381/096089204772787211. View

Schilling P, Davis M, Albanese C, Dutta S, Morton J . National trends in adolescent bariatric surgical procedures and implications for surgical centers of excellence. J Am Coll Surg. 2007; 206(1):1-12. DOI: 10.1016/j.jamcollsurg.2007.07.028. View

Goldner W, Stoner J, Thompson J, Taylor K, Larson L, Erickson J . Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg. 2008; 18(2):145-50. DOI: 10.1007/s11695-007-9315-8. View

Andersen T, McNair P, Hyldstrup L, Nielsen T, Astrup A, TRANSBOL I . Secondary hyperparathyroidism of morbid obesity regresses during weight reduction. Metabolism. 1988; 37(5):425-8. DOI: 10.1016/0026-0495(88)90041-8. View

Yadav V, Ryu J, Suda N, Tanaka K, Gingrich J, Schutz G . Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008; 135(5):825-37. PMC: 2614332. DOI: 10.1016/j.cell.2008.09.059. View

El-Kadre L, Rocha P, de Almeida Tinoco A, Tinoco R . Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2004; 14(8):1062-6. DOI: 10.1381/0960892041975505. View

Fetner R, Mcginty J, Russell C, Pi-Sunyer F, Laferrere B . Incretins, diabetes, and bariatric surgery: a review. Surg Obes Relat Dis. 2006; 1(6):589-97. DOI: 10.1016/j.soard.2005.09.001. View

Henriksen D, Alexandersen P, Bjarnason N, Vilsboll T, Hartmann B, Henriksen E . Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res. 2003; 18(12):2180-9. DOI: 10.1359/jbmr.2003.18.12.2180. View

10.

Mark A, Correia M, Rahmouni K, Haynes W . Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens. 2002; 20(7):1245-50. DOI: 10.1097/00004872-200207000-00001. View

11.

Johnson J, Maher J, Samuel I, Heitshusen D, Doherty C, Downs R . Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg. 2005; 9(8):1106-10. DOI: 10.1016/j.gassur.2005.07.012. View

12.

Crookes P . Surgical treatment of morbid obesity. Annu Rev Med. 2006; 57:243-64. DOI: 10.1146/annurev.med.56.062904.144928. View

13.

Ybarra J, Sanchez-Hernandez J, Perez A . Hypovitaminosis D and morbid obesity. Nurs Clin North Am. 2007; 42(1):19-27, v. DOI: 10.1016/j.cnur.2006.12.001. View

14.

Zhao L, Jiang H, Papasian C, Maulik D, Drees B, Hamilton J . Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 2007; 23(1):17-29. PMC: 2663586. DOI: 10.1359/jbmr.070813. View

15.

le Roux C, Aylwin S, Batterham R, Borg C, Coyle F, Prasad V . Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2005; 243(1):108-14. PMC: 1449984. DOI: 10.1097/01.sla.0000183349.16877.84. View

16.

Carrasco F, Ruz M, Rojas P, Csendes A, Rebolledo A, Codoceo J . Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg. 2008; 19(1):41-6. DOI: 10.1007/s11695-008-9638-0. View

17.

Compher C, Badellino K, Boullata J . Vitamin D and the bariatric surgical patient: a review. Obes Surg. 2008; 18(2):220-4. DOI: 10.1007/s11695-007-9289-6. View

18.

Luo X, Guo L, Yuan L, Xie H, Zhou H, Wu X . Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res. 2005; 309(1):99-109. DOI: 10.1016/j.yexcr.2005.05.021. View

19.

Fleischer J, Stein E, Bessler M, Della Badia M, Restuccia N, Olivero-Rivera L . The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab. 2008; 93(10):3735-40. PMC: 2579647. DOI: 10.1210/jc.2008-0481. View

20.

Karsenty G . Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 2006; 4(5):341-8. DOI: 10.1016/j.cmet.2006.10.008. View